- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Control of Substances Hazardous to Health Regulations 2002, Paragraph 5.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
5.—(1) Subject to sub-paragraphs (7) and (8), an employer shall not use for the first time one or more biological agents in Group 2, 3 or 4 at particular premises for any of the activities listed in paragraph 3(3) unless he has—
(a)notified the Executive in writing of his intention to do so at least 20 working days in advance, or such shorter period as the Executive may allow;
(b)furnished with that notification the particulars specified in sub-paragraph (5); and
(c)received the acknowledgement required by sub-paragraph (4).
(2) Subject to sub-paragraphs (7) and (9), an employer shall not use a biological agent which is specified in Part V of this Schedule, except where the use of that agent has been notified to the Executive in accordance with sub-paragraph (1), for any of the activities listed in paragraph 3(3) unless he has—
(a)notified the Executive in writing of his intention to do so at least 20 working days in advance, or such shorter period as the Executive may allow;
(b)furnished with that notification the particulars specified in sub-paragraph (5); and
(c)received the acknowledgement required by sub-paragraph (4).
(3) The Executive may accept a single notification under sub-paragraph (2) in respect of the use of more than one biological agent by the same person.
(4) Upon receipt of the notification required by sub-paragraph (1) or (2), the Executive shall, within 20 working days—
(a)send to the notifier an acknowledgement of receipt; or
(b)if the notification does not contain all of the particulars specified in sub-paragraph (5)—
(i)inform the notifier in writing of the further particulars required, and
(ii)within 10 working days of receipt of those further particulars, send to the notifier an acknowledgement of receipt.
(5) The particulars to be included in the notification referred to in sub-paragraphs (1) and (2) shall be—
(a)the name and address of the employer and the address of the premises where the biological agent will be stored or used;
(b)the name, qualifications and relevant experience of any employee of that employer with specific responsibility for the health and safety of his fellow employees;
(c)the results of the risk assessment;
(d)the identity of the biological agent and, if the agent does not have an approved classification, the Group to which the agent has been assigned; and
(e)the preventive and protective measures that are to be taken.
(6) Where there are changes to processes, procedures or the biological agent which are of importance to health or safety at work and which render the original notification invalid the employer shall notify the Executive forthwith in writing of those changes.
(7) Sub-paragraphs (1) and (2) shall not apply in relation to a biological agent where an intention to use that biological agent has been previously notified to the Executive in accordance with the Genetically Modified Organisms (Contained Use) Regulations 2000 M1.
(8) The requirement in sub-paragraph (1) to notify first use of a biological agent in Group 2 or 3 shall not apply to an employer whose only use of that agent is in relation to the provision of a diagnostic service provided that use will not involve a process likely to propagate, concentrate or otherwise increase the risk of exposure to that agent.
(9) The requirement in sub-paragraph (2) to notify use of a biological agent specified in Part V of this Schedule shall not apply to an employer whose only use of that agent is in relation to the provision of a diagnostic service provided that use will not involve a process likely to propagate, concentrate or otherwise increase the risk of exposure to that agent.
Marginal Citations
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: